[1]陈建国.结直肠癌患者FOLFOX化疗与GSTP1,XRCC1基因多态性的研究[J].现代检验医学杂志,2016,31(05):66-68，72.[doi:10.3969/j.issn.1671-7414.2016.05.017]
　CHEN Jian-guo.Relationship between FOLFOX Chemotherapy of Colorectal Cancer Patients and GSTP1,XRCC1 Gene Polymorphism[J].Journal of Modern Laboratory Medicine,2016,31(05):66-68，72.[doi:10.3969/j.issn.1671-7414.2016.05.017]
点击复制

结直肠癌患者FOLFOX化疗与GSTP1,XRCC1基因多态性的研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第31卷
期数:
2016年05期
页码:
66-68，72
栏目:
论著
出版日期:
2016-10-21

文章信息/Info

Title:
Relationship between FOLFOX Chemotherapy of Colorectal Cancer Patients and GSTP1,XRCC1 Gene Polymorphism
文章编号:
1671-7414(2016)05-066-04
作者:
陈建国
湖南省肿瘤医院,长沙 410013
Author(s):
CHEN Jian-guo
Tumor Hospital of Hunan Province,Changsha 410013,China
关键词:
结直肠癌;  谷胱甘肽S-转移酶基因;  X线修复交叉互补基因1基因;  基因多态性
分类号:
R735.3; R730.43
DOI:
10.3969/j.issn.1671-7414.2016.05.017
文献标志码:
A
摘要:
目的 探究结直肠癌患者FOLFOX化疗与GSTP1,XRCC1基因多态性的关系。方法 选取湖南省肿瘤医院2014年1月～12月收治的结直肠癌术后患者60例作为研究对象,给予改良FOLFOX方案化疗,并测定患者GSTP1,XRCC1基因序列多态性,统计患者疗效并探究疗效与GSTP1,XRCC1基因序列多态性的关系。结果 患者完全缓解与部分缓解的例数和患者稳定与进展的例数与患者的性别、年龄、肿瘤位置、病理分化、TNM分期无关(χ2=0.136～1.837,P值均>0.05); 携带GSTP1 A/A基因型患者41例(68.3%),携带A/G基因型患者14例(23.3%),携带 G/G基因型患者5例(8.3%),GSTP1基因野生型(A/A)患者治疗有效率低于GSTP1基因突变型(A/G+G/G)患者(χ2=4.493,P=0.034)。携带XRCC1 G/G基因型患者35例(58.3%),携带G/A基因型患者22例(36.7%),携带A/A基因型患者3例(5%),XRCC1基因野生型(G/G)患者治疗有效率高于突变型(G/A+A/A)患者(χ2=4.691,P=0.030)。结论 研究表明结直肠癌患者GSTP1(A/A),XRCC1(G/G)基因多态性与FOLFOX化疗的敏感性相关。
Abstract:
Objective To explore the relationship between FOLFOX Chemotherapy and GSTP1,XRCC1 gene polymorphism in patients with colorectal cancer.Methods 60 cases of colorectal cancer treated in Tumor hospital of Hunan Province from January to December 2014 were selected as the research object.Treat patients with modified FOLFOX regimen,determined the GSTP1,XRCC1 gene sequence polymorphism,and explored the relationship between the efficacy and the GSTP1,XRCC1 gene sequence polymorphism.Results The number of patients with complete remission and partial remission and the number of patients with stable and progress were not related to thegender,age,tumor location,pathological differentiation,TNM staging of patients(χ2=0.222～1.8,P>0.05).Of all cases,the frequencies of GSTP1A/A,A/G and G/G genotype were 68.3%,23.3% and 8.3%,respectively.GSTP1 gene wild-type(A/A)patients were treated with less efficiency than the GSTP1 gene mutation type(A/G+G/G)patients(χ2=4.493,P=0.034).Of all cases,thefrequencies of XRCC1 G/G,G/A and A/A genotype were 58.3%,36.7% and 5%,respectively.XRCC1 gene wild type(G/G)patients with effective rate was higher thanthat of mutant type(G/A+A/A)patients(χ2=4.691,P=0.030).Conclusion The study showed that GSTP1(A/A),XRCC1(G/G)gene polymorphism may be associated with clinical response to FOLFOX chemotherapy in advanced colorectal cancer.

参考文献/References:

[1] 陈 琼,刘志才,程兰平,等.2003～2007年中国结直肠癌发病与死亡分析[J].中国肿瘤,2012,21(3):179-182. Chen Q,Liu ZC,Cheng LP,et al.An analysis of incidence and mortality of colorectal cancer in China,2003～2007[J].China Cancer,2012,21(3):179-182.
[2] Woodson.Epidemic Trend and Countermeasures of Cancer[J].Colorectal Cancer,2011(09):897-902.
[3] 郑民华.腹腔镜结直肠癌手术的现状与展望[J].中国实用外科杂志,2011,31(9):841-843. Zheng MH.The Present Situation and Prospect of Laparoscopic Colorectal Cancer Surgery[J].Chinese Journal of Practical Surgery,2011,31(9):841-843.
[4] 蒋蔚茹,刘 杰.结直肠癌化疗进展[J].中国肿瘤,2011,20(3):200-203. Jiang WR,Liu J.Progress in chemotherapy for colorectal cancer[J].Chinese Cancer,2011,20(3):200-203.
[5] 黄佳莹,张 文.基因多态性预测结直肠癌化疗效果和不良反应[J].肿瘤,2012,30(2):164-169. Huang JY,Zhang W.Gene polymorphisms predict efficacy and toxicityof chemotherapy for colorectal cancer[J].Tumor,2012,30(2):164-169.
[6] 刘 杨.DNA修复基因XRCC1和XRCC3在结直肠癌中的表达及其多态性与化疗后患者生存期关系的研究[D].长沙:中南大学,2013. Liu Y.The expression of DNA repair genes XRCC1 and XRCC3 in the colorectal cancer and prediction of genetic[D].Chongqing:Central South University,2013.
[7] 沈冬亚,周宏灏.MTHFR,GSTP1,ERCC1基因多态性与结直肠癌FOFLOX化疗方案疗效相关性研究[D].重庆:重庆医科大学,2014. Shen DY,Zhou HH.Association of MTHFR,GST-P1,ERCC1 polymorphisms and response to FOFLOX in colorectal cancer patients[D].Chongqing:Chongqing Medical University,2014.
[8] Kumamoto K,Ishibashi K,Okada N,et al.Polymorphisms of GSTP1,ERCC2,and TS-3'UTR are association with the clinical outcome of mFOLFOX in colorectal cancer patients[J].Oncol Lett,2013,6(3):648-654.
[9] Polimanti R,Carbonic C,Baesso I,et al.Genetic variability of glutathione S-transferase enzymes in human populations functional inter-ethnic differences in detoxification systems[J].Gene,2013,512(1):102-107.
[10] Holley SL,Rajagopal R,Hoban PR,et al.Polymorphisms in the glutathione S-transferase mu cluster are associated with tumour progression and patient outcome in colorectal cancer[J].Int J Oncol,2006,28(1):231-236.
[11] L(¨overu)H,Li Q,Qiu W,et al.Genetic polymorphism of XRCC1 correlated with response to oxaliplatin-based chemotherapy in advanced colorectal cancer[J].Cancer Invest,2013,31(1):24-28.
[12] Lamas MJ,Duran G,Gomez A,et al.X-ray cross complenting group1 and thymidylate synthase polymorphisms might predict response to chemotherapy in rectal cancer patients[J].Int J Radiat Oncol Biophys,2012,82(1):138-144.

相似文献/References:

[1]周秋媛,王红莉,李虹,等.NRP-1和NRP-2在结直肠癌组织中的表达水平及临床意义[J].现代检验医学杂志,2016,31(06):85.[doi:10.3969/j.issn.1671-7414.2016.06.024]
　ZHOU Qiu-yuan,WANG Hong-li,LI Hong,et al.Serum NRP-1 and NRP-2 Expression in Colorectal Cancer Patients and Its Relationship with Clinical Pathology[J].Journal of Modern Laboratory Medicine,2016,31(05):85.[doi:10.3969/j.issn.1671-7414.2016.06.024]
[2]史 敏,郭晓波,李思远,等.结直肠癌患者组织中K-ras和BRAF基因突变与不同病理特征的相关性分析[J].现代检验医学杂志,2018,33(03):27.[doi:10.3969/j.issn.1671-7414.2018.03.009]
　SHI Min,GUO Xiao-bo,LI Si-yuan,et al.Correlation of K-ras and BRAF Mutations with Pathological Features in Patients with Colorectal Cancer[J].Journal of Modern Laboratory Medicine,2018,33(05):27.[doi:10.3969/j.issn.1671-7414.2018.03.009]
[3]井丰军,倪勇.结直肠癌患者外周血NLR与RDW的变化及临床意义[J].现代检验医学杂志,2018,33(03):99.[doi:10.3969/j.issn.1671-7414.2018.03.025]
　JING Feng-jun,NI Yong.Change and Significance of Neutrophil/Lymphocyte Ratio and Red Blood Cell Distribution Width of Peripheral Blood in the Colorectal Cancer[J].Journal of Modern Laboratory Medicine,2018,33(05):99.[doi:10.3969/j.issn.1671-7414.2018.03.025]
[4]滕祥云,王新梦,刘　维,等.中国汉族结直肠癌患者 UGT1A1*28基因多态性分析[J].现代检验医学杂志,2019,34(06):20.[doi:10.3969 ／ j.issn.1671-7414.2019.06.005]
　TENG Xiang-yun,WANG Xin-meng,LIU Wei,et al.Polymorphism of UGT1A1*28 Gene in Han Patients with Colorectal Cancer in China[J].Journal of Modern Laboratory Medicine,2019,34(05):20.[doi:10.3969 ／ j.issn.1671-7414.2019.06.005]
[5]陈 培,邓钦木,李丹丹.血浆Septin9 甲基化检测在结直肠癌中的诊断价值[J].现代检验医学杂志,2020,35(04):10.[doi:10.3969/j.issn.1671-7414.2020.04.003]
　CHEN Pei,DENG Qin-mu,LI Dan-dan.Diagnostic Value of Plasma Septin9 Methylation in Screening of Colorectal Cancer[J].Journal of Modern Laboratory Medicine,2020,35(05):10.[doi:10.3969/j.issn.1671-7414.2020.04.003]
[6]杨婕琳a,陈文婷b,胡晓利a.结直肠癌组织中硫氧还蛋白-1与硫氧还蛋白互作蛋白的表达及其临床意义[J].现代检验医学杂志,2021,36(06):22.[doi:10.3969/j.issn.1671-7414.2021.06.005]
　YANG Jie-lin,CHEN Wen-ting,HU Xiao-li.Expression and Clinical Significance of Thioredoxin-1 and Thioredoxin Interacting Protein in Colorectal Cancer[J].Journal of Modern Laboratory Medicine,2021,36(05):22.[doi:10.3969/j.issn.1671-7414.2021.06.005]
[7]马胜辉,崔雪琴,李建华,等.结直肠癌组织miR-485-5p，miR-1207-3p和miR-590-3p水平表达与临床病理特征及生存的相关性研究[J].现代检验医学杂志,2022,37(03):16.[doi:10.3969/j.issn.1671-7414.2022.03.004]
　MA Sheng-hui,CUI Xue-qin,LI Jian-hua,et al.Correlation of miR-485-5p, miR-1207-3p, miR-590-3p Level Expression and Clinicopathologic Characteristics and Survival in Colorectal Cancer Tissue[J].Journal of Modern Laboratory Medicine,2022,37(05):16.[doi:10.3969/j.issn.1671-7414.2022.03.004]
[8]胡道军,史文杰,孙 敏.LncRNA NEAT1/miR-23b-3p/KLF3 轴调控结直肠癌细胞的生物学功能研究[J].现代检验医学杂志,2022,37(04):1.[doi:10.3969/j.issn.1671-7414.2022.04.001]
　HU Dao-jun,SHI Wen-jie,SUN Min.LncRNA NEAT1/miR-23b-3p/ KLF3 Axis Regulates the Biological Function of Colorectal Cancer Cells[J].Journal of Modern Laboratory Medicine,2022,37(05):1.[doi:10.3969/j.issn.1671-7414.2022.04.001]
[9]冯 芬.结直肠癌组织中USP11 和PPP1CA 表达水平与临床病理的相关性研究[J].现代检验医学杂志,2022,37(04):43.[doi:10.3969/j.issn.1671-7414.2022.04.009]
　FENG Fen.Correlation between USP11 and PPP1CA Expression Levels and Clinicopathology in Colorectal Cancer Tissues[J].Journal of Modern Laboratory Medicine,2022,37(05):43.[doi:10.3969/j.issn.1671-7414.2022.04.009]
[10]郑光明,孙建华,宋秋月.结直肠癌组织中锌指蛋白139（ZNF139）的表达及临床意义研究[J].现代检验医学杂志,2022,37(04):107.[doi:10.3969/j.issn.1671-7414.2022.04.021]
　ZHENG Guang-ming,SUN Jian-hua,SONG Qiu-yue.Expression and Clinical Significance of Zinc Finger Protein 139 (ZNF139) in Colorectal Cancer[J].Journal of Modern Laboratory Medicine,2022,37(05):107.[doi:10.3969/j.issn.1671-7414.2022.04.021]

备注/Memo

备注/Memo:

作者简介:陈建国(1969-),男,研究生,副主任技师,主要从事分子生物学检验和细菌耐药性机制研究,Tel:15873360847。
更新日期/Last Update: 2016-10-30